JPRN-UMIN000015017已完成1 期
Amniotic membrane-derived mesenchymal stromal cells for the treatment of steroid-resistant acute GVHD - Amnion MSC for GVHD
Hematology Division, Internal Medicine, Hyogo college of Medicine0 个研究点目标入组 5 人开始时间: 2014年9月8日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1 patients with Liver damage other than GVHD (Total bililubin >2.0mg/dl or AST and/or ALT>200U/L 2 patients with Serum creatinine >2mg/dl 3 patients with allergy to bovine or porcine products 4 patienst with relapsed at MSC infusion 5 patients with uncontrolled infection 6 blood O2 saturation <94% even 3L/min Oxygen supply 7 Patients attending physician has determined ineligible.
研究者
相似试验
已完成
1 期
mbilical cord-derived mesenchymal stromal cells therapy for SARS-CoV-2 infection (COVID-19) related Acute Respiratory Distress SyndromeJPRN-jRCT1080225369Human Life CORD Japan Inc.12
已完成
1 期
Exosomes Derived from placental Mesenchymal Stem Cells as Treatment for Severe COVID-19: Phase 1 & 2 Clinical TrialsAcute Respiratory Distress Syndrome of COVID-19.COVID-19U07.1IRCT20200413047063N2Omid Cell and Tissue center50
已完成
不适用
Development of placenta decidual stromal cellPregnancy, childbirth and the puerperiumKCT0002761The Catholic University of Korea, Seoul St. Mary's Hospital10
进行中（未招募）
不适用
Stem cell therapy in heart failureIschemic heart disease and heart failureMedDRA version: 18.0Level: LLTClassification code 10019279Term: Heart failureSystem Organ Class: 100000004849EUCTR2015-001560-19-DKDepartment of Cardiology, Rigshospitalet
尚未招募
1 期
Amnion cells for COVID-19 related respiratory failureCOVID-19 related respiratory failureRespiratory - Other respiratory disorders / diseasesInfection - Other infectious diseasesACTRN12620000676910Monash Health40